Posted inBusiness
Dr. Reddy’s Delays Semaglutide Rollout Following Quality Control Concerns
Dr. Reddy's halts semaglutide launch due to quality concerns, impacting shares and the race for generic weight-loss and diabetes treatments.
Posted inHealth
GLP-1 Weight Loss Drugs Linked to Reduced Physical Activity, Study Finds
A recent observational study has revealed that individuals prescribed GLP-1 receptor agonists—a class of drugs including Ozempic, Wegovy, and Mounjaro—exhibit a measurable decline in physical activity levels shortly after beginning…
